Moreover, after 12 weeks of VNS treatment, VNS significantly reduced both cardiac and serum TNF-α levels compared with the sham group (Fig. 5B,C), suggesting that VNS attenuated cardiac inflammation and oxidative stress in obese-insulin resistance. The gene discussed is TNF; the disease is Insulin resistance.